Urologic oncology
Comparison of prostate-specific antigen kinetics between androgen receptor signaling inhibitor doublet therapy and androgen receptor signaling inhibitor with docetaxel triplet therapy in patients with metastatic castration-sensitive prostate cancer.
Tsuyoshi Morita, Yutaka Yamamoto, Saizo Fujimoto, Mamoru Hashimoto, Takafumi Minami, Wataru Fukuokaya, Fumihiko Urabe, Takafumi Yanagisawa, Akihito Takeuchi, Ryoichi Maenosono, Takuya Tsujino, Hirofumi Morinaka, Kiyoshi Takahara, Kazumasa Komura, Teruo Inamoto
Published: 202510.1016/j.urolonc.2025.12.004
Abstract
BACKGROUND: Doublet therapy of androgen deprivation therapy (ADT) with androgen receptor signaling inhibitor (ARSI) or triplet therapy of ADT with docetaxel and ARSI represent possible treatment options in patients with metastatic castration-sensitiv…
Preview only. Read the full abstract at the source